chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Tightness in forehead 3 minutes after getting the shot. 5 minutes after getting the shot, tingling in my face and lips occurred, my throat closed and my heart rate shot up to 170 bpm while sitting. Difficult breathing for 15 minutes after getting the shot.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chronic inflammatory demyelinating polyradiculoneuropathy, Condition aggravated, Gait inability, Muscular weakness, Neuralgia
Clinical narrative: severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration in left arm on 16Mar2021 at 17:30 as single dose for COVID-19 immunization. There was no other vaccine in four weeks. The patient previously administered first dose of BNT162B2 (at 55-year-old ), lot Number EN6198 in left arm on 23Feb2021 at 05:30 PM for COVID-19 immunization. Patient's medical history included CIDP from 2008 (previously diagnosed in 2008 and generally well controlled by IVIG therapy), type 2 diabetes mellitus from 2018, asthma, known allergies from tree pollens and grasses. The concomitant medication of patient included insulin degludec (TRESIBA), insulin aspart (FIASP), metformin (METFORMIN). On 20Mar2021, 09:00 AM, the patient experienced severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak. Patient received dose 2 on 16Mar2021. On about 20Mar2021, he experienced a sudden severe relapse of CIDP (previously diagnosed in 2008 and generally well controlled by IVIG therapy). In a few days he went from having reasonably good nerve function, which allowed me to walk, climb stairs and generally engage in life activities, to being so weak I could not climb a 75 cm step or stand from a sitting position unaided. The patient received treatment included Solumedrol 500 mg per day for 3 days, IV. The patient did not have covid prior vaccination and not covid tested post vaccination. The outcome of the events was recovering.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paralysis, Sensory loss
Clinical narrative: severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration in left arm on 16Mar2021 at 17:30 as single dose for COVID-19 immunization. There was no other vaccine in four weeks. The patient previously administered first dose of BNT162B2 (at 55-year-old ), lot Number EN6198 in left arm on 23Feb2021 at 05:30 PM for COVID-19 immunization. Patient's medical history included CIDP from 2008 (previously diagnosed in 2008 and generally well controlled by IVIG therapy), type 2 diabetes mellitus from 2018, asthma, known allergies from tree pollens and grasses. The concomitant medication of patient included insulin degludec (TRESIBA), insulin aspart (FIASP), metformin (METFORMIN). On 20Mar2021, 09:00 AM, the patient experienced severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak. Patient received dose 2 on 16Mar2021. On about 20Mar2021, he experienced a sudden severe relapse of CIDP (previously diagnosed in 2008 and generally well controlled by IVIG therapy). In a few days he went from having reasonably good nerve function, which allowed me to walk, climb stairs and generally engage in life activities, to being so weak I could not climb a 75 cm step or stand from a sitting position unaided. The patient received treatment included Solumedrol 500 mg per day for 3 days, IV. The patient did not have covid prior vaccination and not covid tested post vaccination. The outcome of the events was recovering.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chronic inflammatory demyelinating polyradiculoneuropathy, Disease recurrence
Clinical narrative: severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration in left arm on 16Mar2021 at 17:30 as single dose for COVID-19 immunization. There was no other vaccine in four weeks. The patient previously administered first dose of BNT162B2 (at 55-year-old ), lot Number EN6198 in left arm on 23Feb2021 at 05:30 PM for COVID-19 immunization. Patient's medical history included CIDP from 2008 (previously diagnosed in 2008 and generally well controlled by IVIG therapy), type 2 diabetes mellitus from 2018, asthma, known allergies from tree pollens and grasses. The concomitant medication of patient included insulin degludec (TRESIBA), insulin aspart (FIASP), metformin (METFORMIN). On 20Mar2021, 09:00 AM, the patient experienced severe relapse of CIDP/not climb a 75 cm step or stand from a sitting position unaided/weak. Patient received dose 2 on 16Mar2021. On about 20Mar2021, he experienced a sudden severe relapse of CIDP (previously diagnosed in 2008 and generally well controlled by IVIG therapy). In a few days he went from having reasonably good nerve function, which allowed me to walk, climb stairs and generally engage in life activities, to being so weak I could not climb a 75 cm step or stand from a sitting position unaided. The patient received treatment included Solumedrol 500 mg per day for 3 days, IV. The patient did not have covid prior vaccination and not covid tested post vaccination. The outcome of the events was recovering.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site warmth, Paraesthesia
Clinical narrative: my left arm and the left side of face became very hot; I have pins and needles tingling and numbness along the left side of my body; This is a spontaneous report received from contactable consumer (patient) via Pfizer-sponsored program. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: El6955) via an unspecified route of administration in the left arm on 19Mar2021, 15:45 (at the age of 54-year-old) as a single dose for COVID-19 immunization in Pharmacy or Drug Store. Medical history included left foot surgery in 1997. Patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included liothyronine sodium and levothyroxine sodium (SYNTHROID). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, about 25 minutes after injection, patient left arm and the left side of face became very hot, after that, and still to this day the patient experienced pins and needles tingling and numbness along the left side of body including fingers, arm, face, leg and foot. All on left side. The patient did not receive any treatment for the events. The outcome of the events was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Paraesthesia
Clinical narrative: my left arm and the left side of face became very hot; I have pins and needles tingling and numbness along the left side of my body; This is a spontaneous report received from contactable consumer (patient) via Pfizer-sponsored program. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: El6955) via an unspecified route of administration in the left arm on 19Mar2021, 15:45 (at the age of 54-year-old) as a single dose for COVID-19 immunization in Pharmacy or Drug Store. Medical history included left foot surgery in 1997. Patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included liothyronine sodium and levothyroxine sodium (SYNTHROID). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, about 25 minutes after injection, patient left arm and the left side of face became very hot, after that, and still to this day the patient experienced pins and needles tingling and numbness along the left side of body including fingers, arm, face, leg and foot. All on left side. The patient did not receive any treatment for the events. The outcome of the events was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Blood pressure increased, Syncope
Clinical narrative: fainted/fainting; felt weak and dizzy/weakness; felt weak and dizzy/dizziness; blood pressure was very high; fast heartbeat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8733), via an unspecified route of administration, administered in arm left on 27Mar2021 18:15 (at the age of 46-years-old) as a single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no covid prior vaccination. No other medication in two weeks. No other vaccine in four weeks. On 27Mar2021 18:45, the patient felt weak and dizzy a few minutes after getting the vaccine and then she fainted. The paramedics took her to the ambulance to check her vitals. EKG, blood sugar and blood oxygen was good, but her blood pressure was very high. Clinical course details was reported as she received the first dose of the Pfizer COVID vaccine on 27Mar2021 and she experienced fainting, dizziness, weakness and a fast heartbeat. The patient would like to know if fainting was considered an allergic reaction. The patient would like to know if she should receive the second dose of the vaccine. She received the 1st dose last 27Mar2021 and 2nd dose will be on 17Apr2021. The reported events resulted in doctor or other healthcare professional office/clinic visit. The patient did not received any treatment for the events. The outcome of the events was recovering. The patient did not covid tested post vaccination.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Electrocardiogram, Heart rate increased
Clinical narrative: fainted/fainting; felt weak and dizzy/weakness; felt weak and dizzy/dizziness; blood pressure was very high; fast heartbeat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8733), via an unspecified route of administration, administered in arm left on 27Mar2021 18:15 (at the age of 46-years-old) as a single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no covid prior vaccination. No other medication in two weeks. No other vaccine in four weeks. On 27Mar2021 18:45, the patient felt weak and dizzy a few minutes after getting the vaccine and then she fainted. The paramedics took her to the ambulance to check her vitals. EKG, blood sugar and blood oxygen was good, but her blood pressure was very high. Clinical course details was reported as she received the first dose of the Pfizer COVID vaccine on 27Mar2021 and she experienced fainting, dizziness, weakness and a fast heartbeat. The patient would like to know if fainting was considered an allergic reaction. The patient would like to know if she should receive the second dose of the vaccine. She received the 1st dose last 27Mar2021 and 2nd dose will be on 17Apr2021. The reported events resulted in doctor or other healthcare professional office/clinic visit. The patient did not received any treatment for the events. The outcome of the events was recovering. The patient did not covid tested post vaccination.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Investigation, Oxygen saturation, Syncope
Clinical narrative: fainted/fainting; felt weak and dizzy/weakness; felt weak and dizzy/dizziness; blood pressure was very high; fast heartbeat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8733), via an unspecified route of administration, administered in arm left on 27Mar2021 18:15 (at the age of 46-years-old) as a single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no covid prior vaccination. No other medication in two weeks. No other vaccine in four weeks. On 27Mar2021 18:45, the patient felt weak and dizzy a few minutes after getting the vaccine and then she fainted. The paramedics took her to the ambulance to check her vitals. EKG, blood sugar and blood oxygen was good, but her blood pressure was very high. Clinical course details was reported as she received the first dose of the Pfizer COVID vaccine on 27Mar2021 and she experienced fainting, dizziness, weakness and a fast heartbeat. The patient would like to know if fainting was considered an allergic reaction. The patient would like to know if she should receive the second dose of the vaccine. She received the 1st dose last 27Mar2021 and 2nd dose will be on 17Apr2021. The reported events resulted in doctor or other healthcare professional office/clinic visit. The patient did not received any treatment for the events. The outcome of the events was recovering. The patient did not covid tested post vaccination.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Hypoaesthesia, Pain in extremity
Clinical narrative: immediate crushing feeling on same forearm; hand numbness/numb feeling up back, neck; hand numbness and tingling; headache; seeing orange spots; faint feeling; This is a spontaneous report from a contactable consumer (patient).   A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 56-years of age), dose 1 via an unspecified route of administration, administered in arm right on 26Mar2021 18:00 (Batch/Lot Number: EP7534) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date and unknown if ongoing. She had no covid prior to vaccination. She had not been tested post vaccination. Concomitant medications included calcium and cetirizine hydrochloride (ZYRTEC), and multivitamins, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant. The patient had not taken any other vaccine in four weeks prior to covid-19 vaccine. On 26Mar2021 18:00, the patient experienced immediate crushing feeling on same forearm, hand numbness and tingling, numb feeling up back, neck and headache; she was seeing orange spot; and she had faint feeling. The patient did not receive any treatment for the events. The outcome of the events was recovered with sequel.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Photopsia
Clinical narrative: immediate crushing feeling on same forearm; hand numbness/numb feeling up back, neck; hand numbness and tingling; headache; seeing orange spots; faint feeling; This is a spontaneous report from a contactable consumer (patient).   A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 56-years of age), dose 1 via an unspecified route of administration, administered in arm right on 26Mar2021 18:00 (Batch/Lot Number: EP7534) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date and unknown if ongoing. She had no covid prior to vaccination. She had not been tested post vaccination. Concomitant medications included calcium and cetirizine hydrochloride (ZYRTEC), and multivitamins, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant. The patient had not taken any other vaccine in four weeks prior to covid-19 vaccine. On 26Mar2021 18:00, the patient experienced immediate crushing feeling on same forearm, hand numbness and tingling, numb feeling up back, neck and headache; she was seeing orange spot; and she had faint feeling. The patient did not receive any treatment for the events. The outcome of the events was recovered with sequel.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: immediate crushing feeling on same forearm; hand numbness/numb feeling up back, neck; hand numbness and tingling; headache; seeing orange spots; faint feeling; This is a spontaneous report from a contactable consumer (patient).   A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 56-years of age), dose 1 via an unspecified route of administration, administered in arm right on 26Mar2021 18:00 (Batch/Lot Number: EP7534) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date and unknown if ongoing. She had no covid prior to vaccination. She had not been tested post vaccination. Concomitant medications included calcium and cetirizine hydrochloride (ZYRTEC), and multivitamins, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant. The patient had not taken any other vaccine in four weeks prior to covid-19 vaccine. On 26Mar2021 18:00, the patient experienced immediate crushing feeling on same forearm, hand numbness and tingling, numb feeling up back, neck and headache; she was seeing orange spot; and she had faint feeling. The patient did not receive any treatment for the events. The outcome of the events was recovered with sequel.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: immediate crushing feeling on same forearm; hand numbness/numb feeling up back, neck; hand numbness and tingling; headache; seeing orange spots; faint feeling; This is a spontaneous report from a contactable consumer (patient).   A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 56-years of age), dose 1 via an unspecified route of administration, administered in arm right on 26Mar2021 18:00 (Batch/Lot Number: EP7534) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date and unknown if ongoing. She had no covid prior to vaccination. She had not been tested post vaccination. Concomitant medications included calcium and cetirizine hydrochloride (ZYRTEC), and multivitamins, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant. The patient had not taken any other vaccine in four weeks prior to covid-19 vaccine. On 26Mar2021 18:00, the patient experienced immediate crushing feeling on same forearm, hand numbness and tingling, numb feeling up back, neck and headache; she was seeing orange spot; and she had faint feeling. The patient did not receive any treatment for the events. The outcome of the events was recovered with sequel.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Immediate post-injection reaction, Injection site erythema, Injection site pain
Clinical narrative: slightly faint; Instantly was dizzy; Instantly had tingling in my hands and feet; Turned into cramping in forearms, shins, and calves; mild arm pain; mild headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 (3:00 PM) (Batch/Lot Number: eng206) as SINGLE DOSE for covid-19 immunisation. There was no medical history included. There was no covid prior vaccination, not covid tested post vaccination. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The patient reported that: "Instantly was dizzy and slightly faint upon injection. Instantly had tingling in my hands and feet which still has not gone away (still about 50% as bad 3 weeks later). Turned into cramping in forearms, shins, and calves. Only other symptoms were mild arm pain and mild headache, no fever, no chills." The events occurred on 17Mar2021 at 15:00 (03:00 PM). The outcome of the events was recovering. The events resulted in Doctor or other healthcare professional office/clinic visit. The treatment was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Muscular weakness, Paraesthesia, Syncope
Clinical narrative: slightly faint; Instantly was dizzy; Instantly had tingling in my hands and feet; Turned into cramping in forearms, shins, and calves; mild arm pain; mild headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 (3:00 PM) (Batch/Lot Number: eng206) as SINGLE DOSE for covid-19 immunisation. There was no medical history included. There was no covid prior vaccination, not covid tested post vaccination. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The patient reported that: "Instantly was dizzy and slightly faint upon injection. Instantly had tingling in my hands and feet which still has not gone away (still about 50% as bad 3 weeks later). Turned into cramping in forearms, shins, and calves. Only other symptoms were mild arm pain and mild headache, no fever, no chills." The events occurred on 17Mar2021 at 15:00 (03:00 PM). The outcome of the events was recovering. The events resulted in Doctor or other healthcare professional office/clinic visit. The treatment was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Muscle spasms, Pain in extremity, Paraesthesia
Clinical narrative: slightly faint; Instantly was dizzy; Instantly had tingling in my hands and feet; Turned into cramping in forearms, shins, and calves; mild arm pain; mild headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 (3:00 PM) (Batch/Lot Number: eng206) as SINGLE DOSE for covid-19 immunisation. There was no medical history included. There was no covid prior vaccination, not covid tested post vaccination. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The patient reported that: "Instantly was dizzy and slightly faint upon injection. Instantly had tingling in my hands and feet which still has not gone away (still about 50% as bad 3 weeks later). Turned into cramping in forearms, shins, and calves. Only other symptoms were mild arm pain and mild headache, no fever, no chills." The events occurred on 17Mar2021 at 15:00 (03:00 PM). The outcome of the events was recovering. The events resulted in Doctor or other healthcare professional office/clinic visit. The treatment was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: slightly faint; Instantly was dizzy; Instantly had tingling in my hands and feet; Turned into cramping in forearms, shins, and calves; mild arm pain; mild headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 (3:00 PM) (Batch/Lot Number: eng206) as SINGLE DOSE for covid-19 immunisation. There was no medical history included. There was no covid prior vaccination, not covid tested post vaccination. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The patient reported that: "Instantly was dizzy and slightly faint upon injection. Instantly had tingling in my hands and feet which still has not gone away (still about 50% as bad 3 weeks later). Turned into cramping in forearms, shins, and calves. Only other symptoms were mild arm pain and mild headache, no fever, no chills." The events occurred on 17Mar2021 at 15:00 (03:00 PM). The outcome of the events was recovering. The events resulted in Doctor or other healthcare professional office/clinic visit. The treatment was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Blood glucose decreased, Diarrhoea, Discomfort, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer. A 72-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 23Mar2021 (Batch/Lot Number: EL9267) as an unspecified dose for COVID-19 immunization.  The patient's medical history included diabetes mellitus from 2005 and ongoing Verbatim: Diabetic, pancreatic carcinoma from 2011 to an unknown date Verbatim: Pancreatic cancer, whipple procedure.He says he is a cancer survivor. There was a whipple procedure done and he was given chemo and radiation treatment and he has not had a recurrence or another outbreak of that particular issue, it was pancreatic cancer. There were no concomitant medications.The patient experienced he had normal soreness in the arm, a little discomfort in his body, he took his temperature and it was 99.3 on an unspecified date, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep  on 25Feb2021, had about with some diarrhea on 26Feb2021. The caller is calling about the vaccine stating that he received the vaccine 23Feb2021 and he had normal soreness in the arm and a little discomfort in his body, then last night after about 11PM he started having to go to the bathroom, he was urinating tremendously, like 1-2 times every hour, he was unable to sleep. He is a diabetic but his sugar was no high it was in the 120s, he knows that if it is like 200 or 300 it could make him urinate but his sugar was way away lower and on top of that he took his temperature and it was 99.3. Three hours later or about 2.5 hours later he had a bout with some diarrhea. He says he had not eaten anything unusual or different than he normally eats, he couldn't find anything wrong with that so he has been resting and lying down and hydrating a lot because this was on the direction of his PCP and he says so far he seems to be okay. He doesn't know whether it was a side effect but there was nothing else unusual in they past few days that could explain it, it was an unusual occurrence. He confirms his first dose was on the 23 Feb 2021 and he began having frequent urination around 11 PM 25 Feb 2021. He says it does not seem to be ongoing right now it lasted through the night and seemed to be gone today. He had diarrhea about 9-9:30 this morning, that does not seem to be ongoing right now. The patient underwent  lab tests and procedures which included body temperature: 99.3. The outcome of the events he had normal soreness in the arm, a little discomfort in his body, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep, he took his temperature and it was 99.3, had a bout with some diarrhea was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer. A 72-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 23Mar2021 (Batch/Lot Number: EL9267) as an unspecified dose for COVID-19 immunization.  The patient's medical history included diabetes mellitus from 2005 and ongoing Verbatim: Diabetic, pancreatic carcinoma from 2011 to an unknown date Verbatim: Pancreatic cancer, whipple procedure.He says he is a cancer survivor. There was a whipple procedure done and he was given chemo and radiation treatment and he has not had a recurrence or another outbreak of that particular issue, it was pancreatic cancer. There were no concomitant medications.The patient experienced he had normal soreness in the arm, a little discomfort in his body, he took his temperature and it was 99.3 on an unspecified date, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep  on 25Feb2021, had about with some diarrhea on 26Feb2021. The caller is calling about the vaccine stating that he received the vaccine 23Feb2021 and he had normal soreness in the arm and a little discomfort in his body, then last night after about 11PM he started having to go to the bathroom, he was urinating tremendously, like 1-2 times every hour, he was unable to sleep. He is a diabetic but his sugar was no high it was in the 120s, he knows that if it is like 200 or 300 it could make him urinate but his sugar was way away lower and on top of that he took his temperature and it was 99.3. Three hours later or about 2.5 hours later he had a bout with some diarrhea. He says he had not eaten anything unusual or different than he normally eats, he couldn't find anything wrong with that so he has been resting and lying down and hydrating a lot because this was on the direction of his PCP and he says so far he seems to be okay. He doesn't know whether it was a side effect but there was nothing else unusual in they past few days that could explain it, it was an unusual occurrence. He confirms his first dose was on the 23 Feb 2021 and he began having frequent urination around 11 PM 25 Feb 2021. He says it does not seem to be ongoing right now it lasted through the night and seemed to be gone today. He had diarrhea about 9-9:30 this morning, that does not seem to be ongoing right now. The patient underwent  lab tests and procedures which included body temperature: 99.3. The outcome of the events he had normal soreness in the arm, a little discomfort in his body, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep, he took his temperature and it was 99.3, had a bout with some diarrhea was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Diarrhoea, Discomfort, Insomnia, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer. A 72-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 23Mar2021 (Batch/Lot Number: EL9267) as an unspecified dose for COVID-19 immunization.  The patient's medical history included diabetes mellitus from 2005 and ongoing Verbatim: Diabetic, pancreatic carcinoma from 2011 to an unknown date Verbatim: Pancreatic cancer, whipple procedure.He says he is a cancer survivor. There was a whipple procedure done and he was given chemo and radiation treatment and he has not had a recurrence or another outbreak of that particular issue, it was pancreatic cancer. There were no concomitant medications.The patient experienced he had normal soreness in the arm, a little discomfort in his body, he took his temperature and it was 99.3 on an unspecified date, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep  on 25Feb2021, had about with some diarrhea on 26Feb2021. The caller is calling about the vaccine stating that he received the vaccine 23Feb2021 and he had normal soreness in the arm and a little discomfort in his body, then last night after about 11PM he started having to go to the bathroom, he was urinating tremendously, like 1-2 times every hour, he was unable to sleep. He is a diabetic but his sugar was no high it was in the 120s, he knows that if it is like 200 or 300 it could make him urinate but his sugar was way away lower and on top of that he took his temperature and it was 99.3. Three hours later or about 2.5 hours later he had a bout with some diarrhea. He says he had not eaten anything unusual or different than he normally eats, he couldn't find anything wrong with that so he has been resting and lying down and hydrating a lot because this was on the direction of his PCP and he says so far he seems to be okay. He doesn't know whether it was a side effect but there was nothing else unusual in they past few days that could explain it, it was an unusual occurrence. He confirms his first dose was on the 23 Feb 2021 and he began having frequent urination around 11 PM 25 Feb 2021. He says it does not seem to be ongoing right now it lasted through the night and seemed to be gone today. He had diarrhea about 9-9:30 this morning, that does not seem to be ongoing right now. The patient underwent  lab tests and procedures which included body temperature: 99.3. The outcome of the events he had normal soreness in the arm, a little discomfort in his body, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep, he took his temperature and it was 99.3, had a bout with some diarrhea was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pollakiuria, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer. A 72-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 23Mar2021 (Batch/Lot Number: EL9267) as an unspecified dose for COVID-19 immunization.  The patient's medical history included diabetes mellitus from 2005 and ongoing Verbatim: Diabetic, pancreatic carcinoma from 2011 to an unknown date Verbatim: Pancreatic cancer, whipple procedure.He says he is a cancer survivor. There was a whipple procedure done and he was given chemo and radiation treatment and he has not had a recurrence or another outbreak of that particular issue, it was pancreatic cancer. There were no concomitant medications.The patient experienced he had normal soreness in the arm, a little discomfort in his body, he took his temperature and it was 99.3 on an unspecified date, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep  on 25Feb2021, had about with some diarrhea on 26Feb2021. The caller is calling about the vaccine stating that he received the vaccine 23Feb2021 and he had normal soreness in the arm and a little discomfort in his body, then last night after about 11PM he started having to go to the bathroom, he was urinating tremendously, like 1-2 times every hour, he was unable to sleep. He is a diabetic but his sugar was no high it was in the 120s, he knows that if it is like 200 or 300 it could make him urinate but his sugar was way away lower and on top of that he took his temperature and it was 99.3. Three hours later or about 2.5 hours later he had a bout with some diarrhea. He says he had not eaten anything unusual or different than he normally eats, he couldn't find anything wrong with that so he has been resting and lying down and hydrating a lot because this was on the direction of his PCP and he says so far he seems to be okay. He doesn't know whether it was a side effect but there was nothing else unusual in they past few days that could explain it, it was an unusual occurrence. He confirms his first dose was on the 23 Feb 2021 and he began having frequent urination around 11 PM 25 Feb 2021. He says it does not seem to be ongoing right now it lasted through the night and seemed to be gone today. He had diarrhea about 9-9:30 this morning, that does not seem to be ongoing right now. The patient underwent  lab tests and procedures which included body temperature: 99.3. The outcome of the events he had normal soreness in the arm, a little discomfort in his body, he was urinating tremendously, like 1-2 times every hour/frequent urination, he was unable to sleep, he took his temperature and it was 99.3, had a bout with some diarrhea was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles outbreak on right upper; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ER 8733) at single dose on 28Mar2021  01:00 PM via an unknown route in left arm for Covid-19 immunization. Medical history included HIV. Patient had no allergies to medications, food, or other products. Concomitant drugs included emtricitabine, tenofovir disoproxil fumarate (TRUVADA) and raltegravir potassium (ISENTRESS). Historical vaccine included 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ER 6205) on 07Mar2021 01:00 PM in left arm for Covid-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Shingles outbreak on right upper in back 2 days (as of 06Apr2021) after 2nd dose (onset date 30Mar2021 04:00 PM). The report was not serious. The adverse event result in Emergency room/department or urgent care. Treatment included valacyclovir 1,000 mg and Acyclovir 800 mg. Outcome of the event was not resolved. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest pain, Ejection fraction abnormal, Ejection fraction decreased, Electrocardiogram ST segment elevation
Clinical narrative: Had the chills, aches, and pain the day after the shot however two days out from the second shot being administered on Saturday, went to the ER due to trouble breathing when lying flat on my back. Was diagnosed with Myocarditis, and Cardiologists could not tell me what exactly happened to cause this.  Was a very very scary event in the first place, and is still effecting me to this day.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram T wave abnormal, Fibrin D dimer normal, Left ventricular dysfunction, Magnetic resonance imaging heart, Painful respiration
Clinical narrative: Had the chills, aches, and pain the day after the shot however two days out from the second shot being administered on Saturday, went to the ER due to trouble breathing when lying flat on my back. Was diagnosed with Myocarditis, and Cardiologists could not tell me what exactly happened to cause this.  Was a very very scary event in the first place, and is still effecting me to this day.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Sinus tachycardia, Troponin increased, White blood cell count increased
Clinical narrative: Had the chills, aches, and pain the day after the shot however two days out from the second shot being administered on Saturday, went to the ER due to trouble breathing when lying flat on my back. Was diagnosed with Myocarditis, and Cardiologists could not tell me what exactly happened to cause this.  Was a very very scary event in the first place, and is still effecting me to this day.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dyspnoea, Echocardiogram, Myocarditis, Pain
Clinical narrative: Had the chills, aches, and pain the day after the shot however two days out from the second shot being administered on Saturday, went to the ER due to trouble breathing when lying flat on my back. Was diagnosed with Myocarditis, and Cardiologists could not tell me what exactly happened to cause this.  Was a very very scary event in the first place, and is still effecting me to this day.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antibody test, Platelet count, Platelet count decreased, SARS-CoV-2 antibody test, White blood cell count
Clinical narrative: platelets were very low; This is a spontaneous report from a contactable consumer, the patient, received from a Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received his first dose of BNT162b2 a few weeks ago and he was scheduled for the second dose this Friday. After taking the first dose, he had blood test done on an unspecified date and his platelets were very low. He was wondering if he could take the second dose. Lab data included platelets were very low on an unspecified date. The outcome of event, platelets were very low, was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Platelet count abnormal
Clinical narrative: platelets were very low; This is a spontaneous report from a contactable consumer, the patient, received from a Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received his first dose of BNT162b2 a few weeks ago and he was scheduled for the second dose this Friday. After taking the first dose, he had blood test done on an unspecified date and his platelets were very low. He was wondering if he could take the second dose. Lab data included platelets were very low on an unspecified date. The outcome of event, platelets were very low, was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Platelet count decreased
Clinical narrative: platelets were very low; This is a spontaneous report from a contactable consumer, the patient, received from a Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received his first dose of BNT162b2 a few weeks ago and he was scheduled for the second dose this Friday. After taking the first dose, he had blood test done on an unspecified date and his platelets were very low. He was wondering if he could take the second dose. Lab data included platelets were very low on an unspecified date. The outcome of event, platelets were very low, was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dizziness, Pyrexia, Tinnitus
Clinical narrative: hearing is also coming and going periodically in both ears; I also felt like I was going to pass out about 5 minutes after the shot; Tinnitus in both ears started within about a half hour; I also have some facial numbness/tightness; I also have some facial numbness/tightness; intermittent ear pain; My joints in my feet and the bottom of my feet hurt.; ear fullness; very sensitive to sound; This is a spontaneous report from a contactable consumer. A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right arm on 23Mar2021 at 10:15 (Batch/Lot Number: ER8727) as single dose for COVID-19 immunisation. Medical history included Lyme disease from an unknown date. The patient has no known allergies. The patient is not pregnant. Concomitant medications included colecalciferol (VITAMIN D); probiotics; fish oil all taken for an unspecified indication, start and stop date were not reported. On 23Mar2021 at 10:30 AM, the patient reported of tinnitus in both ears started within about a half hour of receiving first dose. The patient also felt like she was going to pass out about 5 minutes after the shot. The patient also has some facial numbness/tightness that started the same day as her shot (after the shot). The tinnitus, intermittent ear pain, ear fullness was reported as still continuing. The patient reported that her hearing is also coming and going periodically in both ears. The patient was also very sensitive to sound now. The patient's joints in her feet and the bottom of her feet hurt. Therapeutic measures were taken as a result of the events. Treatment of antihistamine and nasal spray was recommended. The patient do not have covid prior to vaccination and was not tested for covid post vaccination. The patient has not recovered from the events.